Literature DB >> 19279033

Androgen circle of polycystic ovary syndrome.

Roy Homburg1.   

Abstract

Although the aetiology of polycystic ovary syndrome (PCOS) is still not known and the search for causative genes is proving elusive, it is generally agreed that hyperandrogenism is at the heart of the syndrome. Here, it is proposed that excess androgens are the root cause of PCOS starting from their influence on the female fetus in programming gene expression, producing the characteristic signs and symptoms which are then exacerbated by a propagation of excess ovarian androgen production from multiple small follicles, anovulation and insulin resistance in the reproductive life-span, thus setting up a vicious perpetual circle of androgen excess. This opinion paper, rather than being a full-scale review, is intentionally biased in support of this hypothesis that androgen excess is the 'root of all evil' in PCOS; in the hope that its acceptance could lead to more direct treatment of the syndrome in all its facets rather than the symptomatic treatment of side effects of androgen excess that we are addressing today.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19279033     DOI: 10.1093/humrep/dep049

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  27 in total

Review 1.  Transgenerational neuroendocrine disruption of reproduction.

Authors:  Deena M Walker; Andrea C Gore
Journal:  Nat Rev Endocrinol       Date:  2011-01-25       Impact factor: 43.330

2.  The efficacy of vitamin D combined with clomiphene citrate in ovulation induction in overweight women with polycystic ovary syndrome: a double blind, randomized clinical trial.

Authors:  Radwa Rasheedy; Hazem Sammour; Abdellatif Elkholy; Yasmine Salim
Journal:  Endocrine       Date:  2020-05-03       Impact factor: 3.633

3.  Premenopausal Circulating Androgens and Risk of Endometrial Cancer: results of a Prospective Study.

Authors:  Tess V Clendenen; Kathryn Hertzmark; Karen L Koenig; Eva Lundin; Sabina Rinaldi; Theron Johnson; Vittorio Krogh; Göran Hallmans; Annika Idahl; Annekatrin Lukanova; Anne Zeleniuch-Jacquotte
Journal:  Horm Cancer       Date:  2016-02-29       Impact factor: 3.869

4.  Effect of orlistat on weight loss, hormonal and metabolic profiles in women with polycystic ovarian syndrome: a randomized double-blind placebo-controlled trial.

Authors:  Ashraf Moini; Mahia Kanani; Ladan Kashani; Reihaneh Hosseini; Ladan Hosseini
Journal:  Endocrine       Date:  2014-10-08       Impact factor: 3.633

5.  Increased expression of kindlin 2 in luteinized granulosa cells correlates with androgen receptor level in patients with polycystic ovary syndrome having hyperandrogenemia.

Authors:  Mei Yang; Juan Du; Danyu Lu; Caixia Ren; Huan Shen; Jie Qiao; Xi Chen; Hongquan Zhang
Journal:  Reprod Sci       Date:  2013-12-13       Impact factor: 3.060

6.  Excess androgen during puberty disrupts circadian organization in female rats.

Authors:  Michael T Sellix; Zachary C Murphy; Michael Menaker
Journal:  Endocrinology       Date:  2013-02-15       Impact factor: 4.736

7.  Efficient derivation of Chinese human embryonic stem cell lines from frozen embryos.

Authors:  Chunliang Li; Ying Yang; Xiaowei Lu; Yijuan Sun; Junjie Gu; Yun Feng; Ying Jin
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-02-26       Impact factor: 2.416

Review 8.  Polycystic ovary syndrome.

Authors:  Zi-Jiang Chen; Yuhua Shi
Journal:  Front Med China       Date:  2010-08-12

9.  Epigenetics in polycystic ovary syndrome: a pilot study of global DNA methylation.

Authors:  Ning Xu; Ricardo Azziz; Mark O Goodarzi
Journal:  Fertil Steril       Date:  2009-11-25       Impact factor: 7.329

10.  Anti-Müllerian hormone gene polymorphism is associated with androgen levels in Chinese polycystic ovary syndrome patients with insulin resistance.

Authors:  Meng-Xue Zheng; Yan Li; Rong Hu; Fei-Miao Wang; Xiao-Mei Zhang; Bing Guan
Journal:  J Assist Reprod Genet       Date:  2016-01-06       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.